No Data
I-PEX, hatch work, etc.
I-PEX <6640> strengthens clean room facilities, enhances MEMS contract manufacturing (Nikkan Kogyo front page).
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of stocks for buy conversion market Code Stock Name Closing Price SAR Main Board ＜1301＞ Gyokuyo 4015 3870 ＜1414＞ Showbond 52775137 ＜1762＞ Takamatsu G 26422563 ＜1766＞ Tokken Corporation 1098010730 ＜1780＞ Yamauura 11801146 ＜1802＞ Obayashi Corporation 21632077 ＜1820＞ Nishimatsu Construction 50964928 ＜187
Kaijom and others continue to rank, with ongoing license agreements with Asahi Kasei Pharma serving as a clue.
Kaiom <4583> has ranked (as of 14:32). It has significantly continued to rise. After the market closed on the 20th, the company announced that it had signed an exclusive licensing agreement with Asahi Kasei Pharma for its therapeutic antibody "Humanized Anti-CX3CR1 Antibody (PFKR)," leading to a stop high yesterday. Today, the buy star continues. In addition to receiving a one-time contract fee of 0.2 billion yen, Kaiom will receive milestone payments of up to approximately 24.8 billion yen depending on the future progress of development and sales. Furthermore, after the product launch, the company will receive...
Asahi Kasei to Merge With Subsidiary for Streamlined Operations
Three key points to pay attention to in the morning session - nvidia's earnings have passed, but individual stocks related to defense and currency etf etc are being selected.
In the trading session on the 21st, attention should be focused on the following three points: ■ The earnings reports for nvidia have passed, but there is individual stock picking related to defense and cryptocurrency. ■ No earnings reports were released. ■ Key materials for the morning session: Sumitomo Corporation, acquisition of agrochemicals in Vietnam, gaining a major distribution network, and pursuing aggressive strategies in a growth market. The Japanese stock market on the 21st is expected to begin with selling pressure, but there may gradually be signs of resilience in market developments. On the 20th, the usa market saw the dow jones industrial average increase by 139 points, and the nasdaq...
Chiome Bioscience Licenses Anti-CX3CR1 Antibody to Asahi Kasei Pharma